跳至主要内容
临床试验/NCT03412851
NCT03412851Unknown不适用

COmparing CeNters ThRombectomy Aspiration STentretriever

Hospitales Universitarios Virgen del Rocío9 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2018年4月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
1,000
试验地点
9
主要终点
modified rankin scale (mRs) at 90 days [effectiveness]

研究概览

简要总结

Our aims is to evaluate the equality in efficacy and safety between direct aspiration technique and stent retriever thrombectomy procedure in anterior circulation strokes in a multicenter, prospective study.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject experiencing an acute ischemic stroke in which imaging demonstrates a vascular occlusion located in the distal internal carotid artery (ICA) through the distal middle cerebral artery (MCA).
  • Subjects in which the aspiration technique is used for at least the first two thrombectomy passes per occluded vessel.
  • Subjects older than 18 yo.
  • Subjects with a prestroke modified Rankin scale of 0-2 and presenting with an NIHSS of 2-
  • Subjects that the operator feels may be treated with endovascular therapy
  • Subjects in which computed tomography (CT)/Magnetic Resonance Imaging (MRI) demonstrates an infarct size of less than 70cc on MRI or Alberta Stroke Program Early CT (ASPECTS) score overall of 6 or better.
  • Subjects in which groin puncture can be obtained within 6 hours of symptom onset (with or without Total Plasminogen Activator administration). In those Patients of more than 8 hours or awake stroke or of unknown onset should be individualized the treatment and must exist area of penumbra in CT perfusion
  • Subjects who have consented in accordance with local Institutional Review Board requirements

排除标准

  • Absence of large vessel occlusion on neuroimaging.
  • Platelet count < 100 x 10³ cells/mm³ or known platelet dysfunction.
  • Contraindication to CT and/or MRI (i.e., due to contrast allergy or prior implant that precludes MRI imaging).
  • Previously documented contrast allergy that is not amenable to medical treatment.
  • Women who are pregnant or breastfeeding at time of intervention.
  • Evidence of brain hemorrhage on CT and/or MRI at presenting hospital.

结局指标

主要结局

modified rankin scale (mRs) at 90 days [effectiveness]

时间窗: 90 days

Is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. Score Description: The scale runs from 0-6, running from perfect health without symptoms to death. 0 No symptoms at all No significant disability despite symptoms; able to carry out all usual duties and activities Slight disability; unable to carry out all previous activities, but able to look after own affairs without assistance Moderate disability; requiring some help, but able to walk without assistance Moderately severe disability; unable to walk without assistance and unable to attend to own bodily needs without assistance Severe disability; bedridden, incontinent and requiring constant nursing care and attention Dead \[Time Frame: 90 days\]

次要结局

  • Symptomatic intracranial bleeding [safety of the technique](First 14 days)
  • Thrombolysis in cerebral infarction (TICI) scale 2b-3 [effectiveness](Up to 24 hours after endovascular reperfusion)

研究者

发起方
Hospitales Universitarios Virgen del Rocío
申办方类型
Other
责任方
Principal Investigator
主要研究者

Alejandro González

Principal Investigator

Hospitales Universitarios Virgen del Rocío

研究点 (9)

Loading locations...

相似试验